When to start and stop?
Lundgren
J D
JD
D017088:AIDS-Related Opportunistic Infections / Q000209:etiology / Q000517:prevention & control; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000009:adverse effects; D018791:CD4 Lymphocyte Count; D015331:Cohort Studies; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods / Q000592:standards; D019317:Evidence-Based Medicine; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006801:Humans; D018579:Patient Selection; D017410:Practice Guidelines as Topic / Q000592:standards*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design / Q000592:standards; D012307:Risk Factors; D013997:Time Factors; D019562:Viral Load
D019380:Anti-HIV Agents